Caribou Biosciences, Inc. (CRBU:NASDAQ) closed at $0.533 on October 23, 2026, down 4.86% on the day. The stock trades 84.9% below its 52-week high of $3.54 and 20.3% above its 52-week low of $0.443. Over the past year, it lost 78.6%. Caribou Biosciences, Inc. is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, CRBU closed higher on 109 days (43%). Its best day was October 20, 2026 (+11.85%) and its worst was October 7, 2026 (-45.64%). The stock moved 10% or more in a single session 8 times. It opened at least 5% above the previous day's high 2 times.
Caribou Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies.
Find more stocks like CRBU with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.